Suchergebnisse - "Yoshida, Akihiro"

PubPharm (8)

1

SLC36A1-mTORC1 signaling drives acquired resistance to CDK4/6 inhibitors

enthalten in: Science advances | 2019

von Yoshida, A. | Bu, Y. | Qie, S. | +7

2

Targeting glutamine-addiction and overcoming CDK4/6 inhibitor resistance in human esophageal squamous cell carcinoma

enthalten in: Nature communications | 2019

von Qie, S. | Yoshida, A. | Parnham, S. | +8

3

A PERK-miR-211 axis suppresses circadian regulators and protein synthesis to promote cancer cell survival

enthalten in: Nature cell biology | 2018

von Bu, Y. | Yoshida, A. | Chitnis, N. | +12

CommentIn: Nat Rev Mol Cell Biol. 2018 Feb;19(2):74-75. - PMID 29259333

4

PERK Is a Haploinsufficient Tumor Suppressor : Gene Dose Determines Tumor-Suppressive Versus Tumor Promoting Properties of PERK in Melanoma

enthalten in: PLoS genetics | 2016

von Pytel, D. | Gao, Y. | Mackiewicz, K. | +12

5

Induction of Therapeutic Senescence in Vemurafenib-Resistant Melanoma by Extended Inhibition of CDK4/6

enthalten in: Cancer research | 2016

von Yoshida, A. | Lee, E. | Diehl, J.

6

COP1 targets C/EBPα for degradation and induces acute myeloid leukemia via Trib1

enthalten in: Blood | 2013

von Yoshida, A. | Kato, J. | Nakamae, I. | +1

7

CSN5 specifically interacts with CDK2 and controls senescence in a cytoplasmic cyclin E-mediated manner

enthalten in: Scientific reports | 2013

von Yoshida, A. | Yoneda-Kato, N. | Kato, J.

8

Depletion of CSN5 inhibits Ras-mediated tumorigenesis by inducing premature senescence in p53-null cells

enthalten in: FEBS letters | 2012

von Tsujimoto, I. | Yoshida, A. | Yoneda-Kato, N. | +1

1
[1]